HENDERSON, Nev.--(BUSINESS WIRE)-- Zura Bio Limited (Nasdaq: ZURA) has announced the issuance of inducement awards to seven new employees, including Eric Hyllengren, the newly appointed Chief Financial Officer. On July 15, 2025, the company granted options to purchase up to 890,950 Class A Ordinary Shares, with 672,000 options awarded to Hyllengren. These awards were approved by the Compensation Committee and the Board, granted outside the 2023 Equity Incentive Plan, and are in alignment with Nasdaq Listing Rule 5635(c)(4). The options will vest incrementally, with one fourth vesting on the vesting commencement date and the remainder vesting in equal quarterly installments, contingent upon continuous service.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。